HYA

N/A

Report date: 2025/05/20 13:43:04
NME

Base Information

Drug NameHYA
Drug Alias Name10-hydroxy-cis-12-octadecenoic acidHYA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases modulatorsFree fatty acid receptor 4 agonistsSodium/glucose cotransporter 1 inhibitors
TargetsAMP-activated protein kinasesFree fatty acid receptor 4Sodium/glucose cotransporter 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNoster Inc
China Registration ClassN/A

Develop Information

Active CompaniesNoster Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A